Email Address / User Name:
Password:
  REGISTER HERE
Why Register?
SqueezeTrigger Info
Naked Short Exposed
Naked Short Update
Naked Short Proof
Phantom Shares
TV commercial
Cramer on Shorts
No Short List
New Short Rules
New Reg SHO
SEC Enforces SHO
New UpTick Rule
Services
  SqueezeTrigger Data
Naked Short Data
SqueezeTrigger    Alerts!
SqueezeTrigger    Reports
SqueezeTrigger    Portfolio
Naked Short List
  New to List
Buyin Imminent
Off List Today

Trade Signals
Performance
  by date
  2010-09-09
2010-09-08
2010-09-07
2010-09-03
2010-09-02
2010-09-01
2010-08-31
2010-08-30
2010-08-27
2010-08-26
2010-08-25
2010-08-24
2010-08-23
2010-08-20
2010-08-19
2010-08-18
2010-08-17
2010-08-16
2010-08-13
2010-08-12
  by exchange
  NASDAQ
AMEX
NYSE
Press Releases
  Naked Short News
SqueezeTrigger News
Friction Factor News
All Releases
Articles
  Bloomberg Article
NY Post Article
New Buyin Rule
Naked Short Article
Naked Short Survey
Naked Shorts Beware
RegSHO Amendment
RegSHO Updated
RegSHO Legal Study
  Contact Us
About Us

Symbol :

OFF LIST - 73 consecutive market days: OFF LIST as of 05/26/2010 Through 09/09/2010

Current Quote
Last:0.570

Bid:
Ask:
Volume:5000

As Of (GMT): 2010-09-10 16:00:00
*Quotes delayed by 20min.
VICOR TECHNOLOGIES INC - Vicor Technologies, Inc., a medical diagnostics company, engages in the development of diagnostic and therapeutic products in the United States. Its diagnostic products are based on the companys patented PD2i algorithm, which is used to predict future pathological events, such as fatal cardiac arrhythmias, imminent death, and autonomic nervous system dysfunction. The company develops its therapeutic products by using a drug discovery platform, which focuses on naturally occurring biomolecules derived from state-dependent physiologies, such as hibernation. Vicor Technologies products include the PD2i Cardiac Analyzer that risk stratifies patients into those at high or low risk of suffering a fatal arrhythmic event, or sudden cardiac death within a six to twelve-month time frame; and PD2i-VS, which is used to assess the severity of injury of critically injured combat casualties to determine the need for an immediate life saving intervention in those trauma victims who are at high risk of imminent death. The companys products also comprise PD2i-Analyzer to diagnose diabetic autonomic neuropathy; and PD2iOR/ICU to utilize a change in the PD2i value as an early warning to surgeons and anesthesiologists of a sharply deteriorating condition in a patient during surgery and also facilitate the assessment of ICU patients being discharged to a step-down unit. It markets its products through in-house sale force and independent distributors to clinical cardiologists, electrophysiologists, family practitioners, and endocrinologists. Vicor Technologies has a collaboration agreement with University of Rochester and the U.S. Army Institute of Surgical Research, as well as an original equipment manufacturing agreement with Nasiff Associates Inc. to integrate its PD2i software into Nasiff's Cardio Card ECG. The company was founded in 2000 and is based in Boca Raton, Florida.


Click Here to Get SqueezeTrigger (TM) Report


Click Here to Get FrictionFactor Report


Click Here For Daily Short Volume Report


Click Here For Real-Time Short Volume Tool




3 Month

6 Month

1 Year